1172 Microsurgical Resection versus Stereotactic Radiosurgery for Trigeminal Schwannoma: A Propensity Score-Matched Multi-Institutional Cohort Study

View at publisher Summarise with VIRAT
Authors: Sean O’Leary, Kwadwo Darko, Francis D. Hussey, Christopher Padilla, Blake Perdikis, Allen Ye Fu, Michael Farid, Umaru Barrie
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Trigeminal schwannomas are rare intracranial tumors with significant implications for cranial nerve function and quality of life. Surgical resection remains a standard approach, but stereotactic radiosurgery (SRS) is increasingly used as a less invasive alternative. METHODS: This retrospective cohort study utilized a large national database to identify patients diagnosed with trigeminal schwannoma who underwent either SRS or microsurgery. Propensity score matching was performed for 6-month and 1-year follow-up cohorts. Matching variables included age, sex, race, ethnicity, comorbidities, as well as baseline cranial nerve complication rates. Clinical outcomes between groups were assessed using odds ratios and kaplan-meier time to event analyses. RESULTS: After matching, 120 patients were included per group at 6 months and 113 per group at 1 year. Baseline characteristics were well balanced across cohorts. At both 6-month and 1-year follow-up, SRS was associated with significantly lower odds of facial nerve disorders (6-month OR 0.35, 95% CI 0.15–0.75, p = 0.006; 1-year OR 0.24, 95% CI: 0.11–0.50, p < 0.001) and visual deficits (6-month OR 0.37, 95% CI: 0.16–0.79, p = 0.010; 1-year OR 0.43, 95% CI: 0.18–0.95, p = 0.036). Time to event analysis showed significantly better outcomes for the SRS group in facial nerve disorder-free survival (p < 0.001), visual deficit-free survival (p = 0.0014) and gabapentinoid-free survival (p = 0.0409). Other outcomes such as pain, headaches, and ER visits showed no statistically significant differences. Mortality was comparable at 1 year (8.70% in both groups). CONCLUSIONS: SRS is associated with reduced rates of cranial nerve complications and medication burden compared to microsurgery in patients with trigeminal schwannoma, without compromising survival.

Fields of Study & Subjects

Meningioma and schwannoma management Trigeminal Neuralgia and Treatments Pituitary Gland Disorders and Treatments

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
227–228
Publication date
26 March 2026
Language
EN